PDL BioPharma to Present at the 2017 RBC Capital Markets Global Healthcare Conference
To access the live and subsequently archived webcast of the presentation, go to the company's website at http://www.pdl.com and go to "Presentations and Events." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.
PDL seeks to provide a significant return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. In late 2012, PDL began providing alternative sources of capital through royalty monetizations and debt facilities and in 2016, began making equity investments in commercial stage companies, the first being Noden Pharma DAC. PDL has committed over
PDL was formerly known as
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pdl-biopharma-to-present-at-the-2017-rbc-capital-markets-global-healthcare-conference-300409359.html
News Provided by Acquire Media